N-(4-(2-oxo-2H-chromen-3-yl)thiazol-2-yl)cyclopropanecarboxamide结构式
|
常用名 | N-(4-(2-oxo-2H-chromen-3-yl)thiazol-2-yl)cyclopropanecarboxamide | 英文名 | N-(4-(2-oxo-2H-chromen-3-yl)thiazol-2-yl)cyclopropanecarboxamide |
|---|---|---|---|---|
| CAS号 | 313469-95-3 | 分子量 | 312.3 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C16H12N2O3S | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | N-(4-(2-oxo-2H-chromen-3-yl)thiazol-2-yl)cyclopropanecarboxamide |
|---|
| 分子式 | C16H12N2O3S |
|---|---|
| 分子量 | 312.3 |
| InChIKey | FSWPZKMGYFIITA-UHFFFAOYSA-N |
| SMILES | C1CC1C(=O)NC2=NC(=CS2)C3=CC4=CC=CC=C4OC3=O |
|
实验名称:Discovery of Small Molecules to Inhibit Human Cytomegalovirus Nuclear Egress
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:HCMV UL50
External Id:HMS1262
|